日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular characterization stratifies VQ myeloma cells into two clusters with distinct risk signatures and drug responses

分子特征分析将VQ型骨髓瘤细胞分为两个具有不同风险特征和药物反应的亚群。

Evan Flietner # ,Mei Yu # ,Govinda Poudel ,Anthony J Veltri ,Yun Zhou ,Adhithi Rajagopalan ,Yubin Feng ,Terra Lasho ,Zhi Wen ,Yuqian Sun ,Mrinal M Patnaik ,Natalie S Callander ,Fotis Asimakopoulos ,Demin Wang ,Jing Zhang

Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment

基质重塑调节肿瘤微环境中树突状细胞的数量和活性

Athanasios Papadas ,Gauri Deb ,Alexander Cicala ,Adam Officer ,Chelsea Hope ,Adam Pagenkopf ,Evan Flietner ,Zachary T Morrow ,Philip Emmerich ,Joshua Wiesner ,Garrett Arauz ,Varun Bansal ,Karla Esbona ,Christian M Capitini ,Kristina A Matkowskyj ,Dustin A Deming ,Katerina Politi ,Scott I Abrams ,Olivier Harismendy ,Fotis Asimakopoulos

Ponatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model

在高风险 VQ 模型中,帕纳替尼可增强骨髓瘤细胞对 MEK 抑制的敏感性

Evan Flietner #, Zhi Wen #, Adhithi Rajagopalan, Oisun Jung, Lyndsay Watkins, Joshua Wiesner, Xiaona You, Yun Zhou, Yuqian Sun, Brock Kingstad-Bakke, Natalie S Callander, Alan Rapraeger, M Suresh, Fotis Asimakopoulos, Jing Zhang